• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Exelixis, Inc. - Common Stock (NQ:EXEL)

    39.21 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 281
    Open 39.21
    Bid (Size) 38.25 (1)
    Ask (Size) 39.20 (3)
    Prev. Close 39.21
    Today's Range 39.21 - 39.21
    52wk Range 27.86 - 49.62
    Shares Outstanding 315,048,788
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    The Ultimate Biotech Stock to Buy With $50 Right Now
    This innovative drugmaker still has plenty of upside potential. 
    Via The Motley Fool
    EXELIXIS INC (NASDAQ:EXEL) Identified as a Quality Value Stock by Fundamental Screening
    Exelixis (EXEL) presents a strong value investment case with low P/E ratios, zero debt, robust profitability, and solid growth in the biotech sector. 
    Via Chartmill

    Performance

    YTD
    +15.5%
    +15.5%
    1 Month
    +0.2%
    +0.2%
    3 Month
    -12.6%
    -12.6%
    6 Month
    +8.3%
    +8.3%
    1 Year
    +33.6%
    +33.6%

    More News

    Read More
    EXELIXIS INC (NASDAQ:EXEL) Stands Out as an Affordable Growth Stock
    Via Chartmill
    Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years
    Via The Motley Fool
    17 Analysts Have This To Say About Exelixis
    Via Benzinga
    Peering Into Exelixis's Recent Short Interest
    Via Benzinga
    Is the Market Bullish or Bearish on Exelixis?
    Via Benzinga
    EXELIXIS INC (NASDAQ:EXEL) Emerges as a Top Undervalued Stock with Strong Fundamentals
    Via Chartmill
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
    From Pomerantz LLP
    Via GlobeNewswire
    Exelixis Inc (NASDAQ:EXEL) Embodies the Affordable Growth Investment Strategy
    Via Chartmill
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
    From Pomerantz LLP
    Via GlobeNewswire
    EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
    From Pomerantz LLP
    Via GlobeNewswire
    Exelixis Announces Appointment of Dana T. Aftab, Ph.D. as Executive Vice President, Research and Development
    From Exelixis, Inc.
    Via Business Wire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
    From Pomerantz LLP
    Via GlobeNewswire
    Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in September
    From Exelixis, Inc.
    Via Business Wire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
    From Pomerantz LLP
    Via GlobeNewswire
    EXELIXIS INC (NASDAQ:EXEL) Emerges as a Compelling Value Investment Opportunity
    Via Chartmill
    EXELIXIS INC (NASDAQ:EXEL) Emerges as a Top Growth at a Reasonable Price (GARP) Stock
    Via Chartmill
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
    From Pomerantz LLP
    Via GlobeNewswire
    Exelixis Inc (NASDAQ:EXEL): A Strong Growth Stock with Bullish Technical Setup
    Via Chartmill
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL
    From Pomerantz LLP
    Via GlobeNewswire
    The Analyst Verdict: Exelixis In The Eyes Of 19 Experts
    Via Benzinga

    Frequently Asked Questions

    Is Exelixis, Inc. - Common Stock publicly traded?
    Yes, Exelixis, Inc. - Common Stock is publicly traded.
    What exchange does Exelixis, Inc. - Common Stock trade on?
    Exelixis, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Exelixis, Inc. - Common Stock?
    The ticker symbol for Exelixis, Inc. - Common Stock is EXEL on the Nasdaq Stock Market
    What is the current price of Exelixis, Inc. - Common Stock?
    The current price of Exelixis, Inc. - Common Stock is 39.21
    When was Exelixis, Inc. - Common Stock last traded?
    The last trade of Exelixis, Inc. - Common Stock was at 10/16/25 04:00 PM ET
    What is the market capitalization of Exelixis, Inc. - Common Stock?
    The market capitalization of Exelixis, Inc. - Common Stock is 12.35B
    How many shares of Exelixis, Inc. - Common Stock are outstanding?
    Exelixis, Inc. - Common Stock has 12B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.